Macular Edema Therapeutics Market

Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).
Macular Edema Therapeutics Market contains market size and forecasts of Macular Edema Therapeutics in Global, including the following market information:
Global Macular Edema Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Macular Edema Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Laser Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Macular Edema Therapeutics include Allergan, Novartis, Roche, Regeneron Pharmaceuticals, Pfizer, Bayer, Boehringer Ingelheim, Bausch & Lomb and Aciont, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Macular Edema Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Macular Edema Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Macular Edema Therapeutics Market Segment Percentages, by Type, 2021 (%)
Laser Treatment
Anti-VEGF Injection
Anti-Inflammatory Treatment
Vitrectomy
Global Macular Edema Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Macular Edema Therapeutics Market Segment Percentages, by Application, 2021 (%)
Cystoid Macular Edema (CME)
Diabetic Macular Edema(DME)
Global Macular Edema Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Macular Edema Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Macular Edema Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Macular Edema Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Novartis
Roche
Regeneron Pharmaceuticals
Pfizer
Bayer
Boehringer Ingelheim
Bausch & Lomb
Aciont
ActiveSite Pharmaceuticals
Adverum Biotechnologies
Aerpio Therapeutics
Ampio Pharmaceuticals
Araim Pharmaceuticals
Astellas Pharma